B6;129-Kidins220tm1.2Fces/Cnrm

Status

Available to order

EMMA IDEM:14667
International strain nameB6;129-Kidins220tm1.2Fces/Cnrm
Alternative nameKidins220KO
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolKidins220tm1.2Fces,
Gene/Transgene symbolKidins220

Information from provider

ProviderFabrizia Cesca
Provider affiliationDepartment of Life Sciences, University of Trieste
Additional ownerProf Giampietro Schiavo, Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
Genetic informationA Kidins220 cDNA (encoding exon 16 and downstream exons) and polyA cassette flanked by two loxP sites was inserted in the unique NruI site within exon 16 of the mKidins220 gene. In Kidins220lox/lox mice, Kidins220 mRNA is transcribed under the control of its endogenous promoter, generating the full-length protein. Female lox/lox mice were crossed with males expressing cre recombinase under the ubiquitous phosphoglycerate kinase promoter, which is active from early stages of embryogenesis (Cesca et al, Cell Death Diff, 2012). Thus, this mouse line carries the constitutive deletion of the Kidins220 protein.
Phenotypic informationHomozygous:
When in homozygosis, embryos die at late stages of development, showing extensive cell death in the central and peripheral nervous system, as well as anomalies in the cardiovascular system (Cesca et al, Cell Death Diff 2012; Cesca et al, Cell Death Dis 2011).

Heterozygous:
The mouse strain kept in heterozygosis is viable, with normal life span and normal breeding capabilities.
Breeding historyMice have been always bred on C57BL/6 background.
References
  • Kidins220/ARMS is an essential modulator of cardiovascular and nervous system development.;Cesca F, Yabe A, Spencer-Dene B, Arrigoni A, Al-Qatari M, Henderson D, Phillips H, Koltzenburg M, Benfenati F, Schiavo G, ;2011;Cell death & disease;2;e226; 22048169
  • Kidins220/ARMS mediates the integration of the neurotrophin and VEGF pathways in the vascular and nervous systems.;Cesca F, Yabe A, Spencer-Dene B, Scholz-Starke J, Medrihan L, Maden C H, Gerhardt H, Orriss I R, Baldelli P, Al-Qatari M, Koltzenburg M, Adams R H, Benfenati F, Schiavo G, ;2012;Cell death and differentiation;19;194-208; 22048155
  • A developmental stage- and Kidins220-dependent switch in astrocyte responsiveness to brain-derived neurotrophic factor.;Jaudon Fanny, Albini Martina, Ferroni Stefano, Benfenati Fabio, Cesca Fabrizia, ;2021;Journal of cell science;134;18045-18055; 34279618
  • Functional Interaction between the Scaffold Protein Kidins220/ARMS and Neuronal Voltage-Gated Na+ Channels.;Cesca Fabrizia, Satapathy Annyesha, Ferrea Enrico, Nieus Thierry, Benfenati Fabio, Scholz-Starke Joachim, ;2015;The Journal of biological chemistry;290;e35785; 26037926
  • Kidins220/ARMS is a novel modulator of short-term synaptic plasticity in hippocampal GABAergic neurons.;Scholz-Starke Joachim, Cesca Fabrizia, Schiavo Giampietro, Benfenati Fabio, Baldelli Pietro, ;2012;PloS one;7;1505-1519; 22563401
  • Kidins220/ARMS controls astrocyte calcium signaling and neuron-astrocyte communication.;Jaudon Fanny, Chiacchiaretta Martina, Albini Martina, Ferroni Stefano, Benfenati Fabio, Cesca Fabrizia, ;2020;Cell death and differentiation;27;; 31624352
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

    • Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome / Orphanet_521390

Literature references

  • Kidins220/ARMS is an essential modulator of cardiovascular and nervous system development.;Cesca F, Yabe A, Spencer-Dene B, Arrigoni A, Al-Qatari M, Henderson D, Phillips H, Koltzenburg M, Benfenati F, Schiavo G, ;2011;Cell death & disease;2;e226; 22048169
  • Kidins220/ARMS mediates the integration of the neurotrophin and VEGF pathways in the vascular and nervous systems.;Cesca F, Yabe A, Spencer-Dene B, Scholz-Starke J, Medrihan L, Maden C H, Gerhardt H, Orriss I R, Baldelli P, Al-Qatari M, Koltzenburg M, Adams R H, Benfenati F, Schiavo G, ;2012;Cell death and differentiation;19;194-208; 22048155
  • A developmental stage- and Kidins220-dependent switch in astrocyte responsiveness to brain-derived neurotrophic factor.;Jaudon Fanny, Albini Martina, Ferroni Stefano, Benfenati Fabio, Cesca Fabrizia, ;2021;Journal of cell science;134;18045-18055; 34279618
  • Functional Interaction between the Scaffold Protein Kidins220/ARMS and Neuronal Voltage-Gated Na+ Channels.;Cesca Fabrizia, Satapathy Annyesha, Ferrea Enrico, Nieus Thierry, Benfenati Fabio, Scholz-Starke Joachim, ;2015;The Journal of biological chemistry;290;e35785; 26037926
  • Kidins220/ARMS is a novel modulator of short-term synaptic plasticity in hippocampal GABAergic neurons.;Scholz-Starke Joachim, Cesca Fabrizia, Schiavo Giampietro, Benfenati Fabio, Baldelli Pietro, ;2012;PloS one;7;1505-1519; 22563401
  • Kidins220/ARMS controls astrocyte calcium signaling and neuron-astrocyte communication.;Jaudon Fanny, Chiacchiaretta Martina, Albini Martina, Ferroni Stefano, Benfenati Fabio, Cesca Fabrizia, ;2020;Cell death and differentiation;27;; 31624352

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).